Graph Therapeutics
Graph Therapeutics44About
What does Graph Therapeutics do?
Graph Therapeutics is a next-generation techbio company focused on developing precision medicines for inflammatory and immune-mediated diseases. They leverage a proprietary 'lab-in-the-loop' AI platform that combines perturbation modeling of live patient samples, functional and multi-omics profiling, and advanced machine learning to understand immune dysfunction at scale. By analyzing real patient tissue, Graph identifies disease mechanisms, novel therapeutic targets, and biomarkers to create di…
What is Graph Therapeutics's revenue?
StartupHub estimates Graph Therapeutics's annual revenue at $514K (range $158K to $2.2M, 35% confidence), based on comparable companies in the sector.
What is Graph Therapeutics's valuation?
StartupHub estimates Graph Therapeutics's effective valuation at $18.6M (range $12.5M to $30.0M, 24% confidence), based on comparable companies in the sector.
How much funding has Graph Therapeutics raised?
Graph Therapeutics has raised a total of $5M in funding. The most recent round on record is Funding Round.
Where is Graph Therapeutics headquartered?
Graph Therapeutics is headquartered in Boston, Austria.
When was Graph Therapeutics founded?
Graph Therapeutics was founded in 2021.
What industry does Graph Therapeutics operate in?
Graph Therapeutics operates in Biotechnology, Artificial Intelligence, Healthcare, Drug Discovery, Precision Medicine, Biotech.
Galatek develops AI-driven automation solutions for life sciences laboratories and advanced semiconductor manufacturing, focusing on precision and reproducibility.
Digital batch record software for pharmaceutical and biotech manufacturing.
Develops and commercializes treatments for central nervous system disorders, including Rett syndrome.
A deep-tech company developing nanorobotic solutions for healthcare, initially targeting dental care applications.
MatrixCode is a research focus at the Freiburg Institute for Advanced Studies (FRIAS) investigating matrisome pathology.
A company focused on privacy, Zcash accumulation, and developing cancer therapeutics.
An entrant is a company tagged Biotechnology whose domain was first registered in the window, counted from registry records in the StartupHub directory. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.